Treatment with neuraminidase inhibitors for high-risk patients with influenza: why is adherence to antiviral treatment recommendations so low?
J Infect Dis
.
2014 Aug 15;210(4):510-3.
doi: 10.1093/infdis/jiu227.
Epub 2014 Apr 13.
Authors
Mary Lou Lindegren
1
,
William Schaffner
1
Affiliation
1
Vanderbilt University School of Medicine, Nashville, Tennessee.
PMID:
24731958
DOI:
10.1093/infdis/jiu227
No abstract available
Keywords:
adherence; antiviral treatment; influenza.
Publication types
Editorial
Comment
MeSH terms
Antiviral Agents / therapeutic use*
Female
Humans
Influenza, Human / drug therapy*
Influenza, Human / epidemiology*
Male
Patient Acceptance of Health Care*
Substances
Antiviral Agents